Merit Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$913K	Buy	7,264 +3,111	+75%	+$391K	0.01%	834
2025 Q1	$459K	Buy	4,153 +345	+9%	+$38.2K	0.01%	970
2024 Q4	$520K	Buy	+3,808	New	+$520K	0.01%	715
2023 Q4	–	Sell	-2,479	Closed	-$279K	–	809
2023 Q3	$279K	Buy	+2,479	New	+$279K	0.01%	604